Bacterial isolation and antimicrobial susceptibilities in patients with infective endocarditis

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 35, Issue 4, 2004, Pages 897-901

  Srifuengfung, Somporn ^a   Yungyuen, Thitiya ^a   Komolpis, Podjanee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; MEROPENEM; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; BACTERIAL ENDOCARDITIS; BACTERIUM DETECTION; BACTERIUM ISOLATION; BLOOD CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ESCHERICHIA COLI; GRAM NEGATIVE AEROBIC RODS AND COCCI; HOSPITAL ADMISSION; HUMAN; NONHUMAN; REVIEW; STAPHYLOCOCCUS AUREUS;

EID: 12444341309     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Anderson MJ, Janoff EN. Klebsiella endocarditis: report of two cases and review. Clin Infect Dis 1998; 26: 468-74.
2. Bayer AS. Infective endocarditis. Clin Infect Dis 1993; 17: 313-22.
3. Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 2001; 14: 177-207.
4. Choudhury R, Grover A, Varma J, et al. Active infective endocarditis observed in an Indian hospital 1981-1991. Am J Cardiol 1992; 70: 1453-8.
5. Dajani AS, Bawdon RE, Berry MC. Oral amoxicillin as prophylaxis for end: what is the optimal dose? Clin Infect Dis 1994; 18: 157-60.
6. Dajani AS, Taubert KA, Wilson W et al. Prevention of bacterial endocarditis recommendation by the American Heart Association. JAMA 1997; 277: 1794-801.
7. Gilbert DN, Wood CA, Kimbrough RC, The Infectious Diseases Consortium of Oregon. Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. Antimicrob Agents Chemother 1991; 35: 79-87.
8. Khan GQ, Kadri SM, Hassan G, Shahid IT, Gazanfar A, Kak M. Salmonella typhi endocarditis : a case report. J Clin Pathol 2003; 56: 801-2.
9. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manuals of clinical microbiology, 8th ed.; 2003: 65-8.
10. Mylonakis E, Calderwood S. Infective endocarditis in adults. N Engl J Med 2001; 345: 1318-28.
11. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial laboratory testing. Fourtheen informational supplement M100-S13. Villanova, Pa: National Committee for Clinical Laboratory Standards, 2004.
12. Petal R, Piper KE, Rouse MS, Cockerill FR III, Steckelberg JM. Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20-year experience. J Clin Microbiol 2000; 38: 4262-3.
13. Strom BL, Abrutyn E, Berlin JA, et al. Risk factors of infective endocarditis: oral and hygiene and nondental exposures. Circulation 2000; 102: 2842-8.
14. Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci and HACEK microorganism. JAMA 1995; 274: 1706-13.